Mali

in page functions
[French]
Mali
Total population (2017) 18,689,959
Birth cohort (2017) 782,368
Surviving Infants (surviving to 1 year per year, 2017) 726,262
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 75/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 115/1000
World Bank Index, IDA (2015) 3.38
Gross Nation Income (per capita US$, 2015) 760
Co-financing group (2017) Initial self-financing
No. of districts/territories (2016) 65

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Mali

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $179,917,364 $191,462,364 $184,970,377
Cash Support (CASHSUPP) $160,000 $185,000 $160,000 100%
Health system strengthening (HSS 1) $4,575,800 $4,575,800 $4,575,800 100%
Health system strengthening (HSS 2) $8,640,000 $20,160,000 $8,640,000 100%
HepB mono (NVS) $1,689,699 $1,689,699 $1,689,699 100%
HPV Demo (NVS) $344,845 $344,845 $344,845 100%
Immunisation services support (ISS) $5,004,607 $5,004,607 $5,004,607 100%
Injection Safety Devices (NVS) $399,500 $399,500 $498,104 125%
Injection safety support (INS) $666,222 $666,222 $666,222 100%
IPV (NVS) $1,384,198 $1,384,198 $1,322,998 96%
Meningitis A (NVS) $648,711 $648,711 $659,634 102%
Meningitis A - mini catch-up campaign (NVS) $2,725,500 $2,725,500 $2,811,767 103%
Meningitis A - mini catch-up op.costs (OPC) $2,175,637 $2,175,637 $2,175,637 100%
Penta (NVS) $46,691,399 $46,691,399 $45,763,798 98%
Pneumo (NVS) $74,009,084 $74,009,084 $80,088,020 108%
Rotavirus (NVS) $22,141,137 $22,141,137 $21,899,242 99%
Vaccine Introduction Grant (VIG) $1,801,703 $1,801,703 $1,801,703 100%
Yellow Fever (NVS) $6,859,322 $6,859,322 $6,868,301 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mali DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 73%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2011) 63.30%
Household survey: DTP3 coverage for female (2011) 62.80%
Household survey: Last DTP3 survey (2011) 63%
% districts achieving > 80% DTP3 coverage (2016) 82%
% districts achieving < 50% DTP3 coverage (2016) 3%
MCV WHO/UNICEF estimates (2016) 75%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$23,023,969 $161,946,408

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mali

25 April 2017

Central African Republic, a mother and her two children.

Central African Republic: mother spreads word about meningitis A vaccine

Izimili Raude knows that her community must rely on vaccines, not miracles, to spare children from a deadly disease.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

09 February 2016

animation

New data confirms immunisation as a best buy in public health

Johns Hopkins University study shows 16-fold return on investment in immunisation from 2011 to 2020

close icon

modal window here